EvaluatePharma - Kirin - Worldwide

Kirin

All Financial Data in US $ (mln)Show in reporting currency

Worldwide

Overview

Company News

Termination of Merger Negotiations With Suntory
Kirin (February 08, 2010)

Kirin Revises Non-consolidated Earnings Forecasts for the Fiscal Year 2009
Kyowa Hakko Kirin (January 25, 2010)

Launch of New Group Structure in Oceania
Kirin (October 21, 2009)

Updated Process of Making Lion Nathan a Wholly-Owned Subsidiary of Kirin Holdings Company
Kirin (September 17, 2009)

Displaying 10 out of a possible 92 unique stories.
Results Sorted By date
Display All Stories

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile



Profile	1 OCT 2008: Kyowa Hakko & Kirin Pharma's merger completed to form Kyowa Hakko Kirin. 1 APR 2008: Kyowa Hakka Kogyo and Kirin Pharma Company merge to form Kyowa Hakko Kirin in a stock-for-stock transaction. Kirin, a Japan based Brewery with a small pharmaceuticals division specialising in Cancer and Nephrology. 1984+: Joint venture between Kirin and Amgen developed Epogen & Neupogen products. NOTE: EvaluatePharma does not include total group financial statements for Kirin because they are not reflective of their Pharmaceutical business.
Listed or Private Company	Listed
Company Classification	-
Company Website	Website

Full Company Profile Information

Top 3 Products (Worldwide Sales 2007/08)

				Annual Sales WW - Sales		Growth per Year (%)
Rank¹	Product	Generic Name	Therapeutic Subcategory	2007	2008	2008
1	Espo	epoetin alfa	Anti-anaemics	355²	95³	-73%
2	Nesp	darbepoetin alfa	Anti-anaemics	43	36⁴	-14%
3	Gran	filgrastim	Immunostimulants	129⁵	35⁶	-73%

Note: Shaded Cells⁷

Therapy Area Focus in 2008

Kirin
	2008
WW Rx & OTC Sales By Therapy Area
Main Categories
Blood	131
Endocrine	16
Oncology & Immunomodulators	35
Various	7
Other Rx & OTC Pharma	7

EvaluatePharma® Coverage of Marketed and Pipeline Products


	Product Count
Kirin ⁸	18

2009 Product Sales analysis
2009 Pharmaceutical Sales
2009 Market Share & Global Ranking
Download to Excel
Search 2 yrs of company press releases

Ranked on:
Annual Sales WW
2008

Group Total: Equals the sum of values in report based on report grouping.

Note: Where Top 5,10,100 etc filters have been applied, the aggregate value relates to the total of the original unfiltered group - not the displayed filtered data. Where n/a appears, a value has been hidden but is included in Group Total.

Examples:

e.g. Top 100 drugs reports. These are not grouped but are filtered to show only the top 100 products by sales in a particular year. The Group Total displayed is equal to the sum of all data within Evaluate Pharma - not just the top 100 products i.e. total market size.

e.g. Global Majors - Top 10 products. Report is grouped by Company and filtered to show only the top 10 products by sales in a particular year. Group Totals are displayed for each company and are equal to the sum of all available data for that company - not just the top 10 products.

XXXXXXXX XXXXXXX:

XXXXX XXXXXXX XXXXXXXXX XXXXX XXXXXX XX XXXXX'X XXX XXXXX XXXXX.

XXXX XXXXXX XXXX XXXXXXX XXXXX XXXX XXXXXX XXX% XX XXXXXXXXX XXXXXXXX XXX XXXX XXXXXXXXX XXX XXXXXXXXXXX XX XX-XXXXXXXXX XXXXXXXXX XXXX XXXXXX.

XXXXXXXXXXXXXX XXXXXXX:

XXXXX XXXXXXX XXX XXXXXXX XXXX XX XXXXXXXX XXXXX XXXXXX XXXXX XXXXX XXXXXXXXXXX.
XXXXX XXXXXXX XXXX XXXXXXXXX XXXXX XXXXXX XX XXXXX'X XXX XXXXX XXXXX.

XXXX XXXXXX XXXX XXXXXXX XXXXX XXXX XXXXXX XXX% XX XXXXXXXXX XXXXXXXX XXX XXXX XXXXXXXXX XXX XXXXXXXXXXX XX XX-XXXXXXXXX XXXXXXXXX XXXX XXXXXX.

XXXXXXXXXXXXXX XXXXXXX:

XXXXX XXXXXXX XXX XXXXXXX XXXX XX XXXXXXXX XXXXX XXXXXX XXXXX XXXXX XXXXXXXXXXX.
XXXXX XXXXXXX XXXX XXXXXXXXX XXXXX XXXXXX XX XXXXX'X XXX XXXXX XXXXX.

Shaded Cells

A shaded cell signifies potentially incomplete data. E.g. A shaded cell in "Change (+/-)" means there is no corresponding value, i.e. there is data for 2001, but no data for 2000. This could signify a product launch, first time disclosure of sales, a product acquisition or missing data.

A shaded cell containing n/a signifies valid data followed by blank or zero values. E.g. A shaded cell containing n/a in "Change (+/-)" means a value is present for 2000, but blank for 2001. This could signify a product disposal / withdrawal, discontinuation of disclosure or missing data.